Difficulty: Medium
Average Score: 88%
Practice
The primary objective for designing drugs that selectively inhibit COX-2 is to
Correct answer
C
Rationale
The correct answer is C) Lower the risk of gastrointestinal toxicity. Selective COX-2 inhibitors were developed to address the issue of gastrointestinal complications associated with traditional nonsteroidal anti-inflammatory drugs (NSAIDs). COX-2 inhibitors target the cyclooxygenase-2 enzyme, which is responsible for inflammation and pain, while sparing the COX-1 enzyme, which helps maintain the stomach lining. By selectively inhibiting COX-2, these drugs reduce inflammation without significantly affecting the stomach lining, thus lowering the risk of gastrointestinal side effects such as ulcers and bleeding.
Option A) Decrease the risk of nephrotoxicity is incorrect because COX-2 inhibitors do not primarily target kidney toxicity. Option B) Improve anti-inflammatory effectiveness is incorrect because while COX-2 inhibitors do improve anti-inflammatory effects, the primary focus is on reducing gastrointestinal side effects. Option D) Reduce the cost of treatment of rheumatoid arthritis is incorrect as the primary objective of COX-2 inhibitors is not cost reduction but rather reducing gastrointestinal complications.
In an educational context, understanding the rationale behind developing selective COX-2 inhibitors is crucial for healthcare professionals to make informed decisions when prescribing medications for pain and inflammation. By grasping the mechanism of action and intended benefits of these drugs, nurses and pharmacists can better educate patients on the importance of medication adherence and potential side effects. This knowledge also helps in optimizing patient care by selecting the most appropriate treatment options based on individual risk factors and preferences.
Option A) Decrease the risk of nephrotoxicity is incorrect because COX-2 inhibitors do not primarily target kidney toxicity. Option B) Improve anti-inflammatory effectiveness is incorrect because while COX-2 inhibitors do improve anti-inflammatory effects, the primary focus is on reducing gastrointestinal side effects. Option D) Reduce the cost of treatment of rheumatoid arthritis is incorrect as the primary objective of COX-2 inhibitors is not cost reduction but rather reducing gastrointestinal complications.
In an educational context, understanding the rationale behind developing selective COX-2 inhibitors is crucial for healthcare professionals to make informed decisions when prescribing medications for pain and inflammation. By grasping the mechanism of action and intended benefits of these drugs, nurses and pharmacists can better educate patients on the importance of medication adherence and potential side effects. This knowledge also helps in optimizing patient care by selecting the most appropriate treatment options based on individual risk factors and preferences.